TrialCancer medicine2021

Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

Amélie Deleporte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.